From custom lipids to plant-derived medical solutions, we create special kinds of products that improve millions of lives in a thousand different ways. Here, we’re always striving to adapt for the better. Join our team to make an impact you’ll feel proud of. At our Lafayette, Vancouver, and Birmingham sites, you support the production of lipid nanoparticles for mRNA vaccines.
In Canada and the USA, Evonik has been developing and producing lipid nanoparticles (LNPs) for years. LNPs are absolutely essential for the effectiveness of mRNA-based vaccines: These ultrafine particles made of fats and waxes envelop the mRNA and transport it into human cells. Without the protective sheath of LNPs, the mRNA would disintegrate inside the body within seconds. Evonik supplies this crucial technology and you can become part of it. Our Evonik Health Care sites at Lafayette, Vancouver, and Birmingham are looking for you!
Evonik wants to find solutions to real-world problems with innovative ideas, teamwork, and practical solutions to make the world at Evonik a better place. The production and supply of lipids for the production of mRNA vaccines are part of this. Learn more about innovation and working at Evonik in our #WhyWeDoIt video. In our campaign #WhyWeDoIt, employees tell us what they appreciate about their work and why they do what they do every day.
Tippecanoe Laboratories, affectionally known as “Tippe” is the second largest Evonik manufacturing site in North America with nearly 700 employees. Starting production in 1954 with just natural fermentation in large molecule manufacturing, Tippe now is a production facility that utilizes fermentation and chemical synthesis processes for the manufacture of many products from a scale of 30-gallon reactors in the kilo-scale pilot plant to 65,000-gallon fermentors! The manufacturing units at the site follow cGMP (current Good Manufacturing Practices) to develop and manufacture active pharmaceutical ingredients, including highly potent ones for cancer medications.
In 2022, Tippe was named the future home to a new, highly flexible, global-scale production facility for pharmaceutical lipids in the United States. This 220 million dollar project will create a new facility at the site with four production trains and a scale of processing vessels in the 15-gallon to 1,000-gallon range. Evonik Health Care gains the capability of rapidly producing high volumes of lipids in the case of a pandemic and furthers its strategy of delivering products and services along the entire drug delivery value chain for cell and gene therapies.
The 36-month-long project has a large, international project team with members in every discipline. This investment will have a dramatic impact on society with the U.S. government funding the facility with up to US $150 million through its Biomedical Advanced Research and Development Authority (BARDA), a component of the Office of the Administration for Strategic Preparedness and Response (ASPR) in the U.S. Department of Health and Human Services. The project team is looking for motivated talent to join the group and drive this rewarding project through the finish line.
Evonik’s Health Care Vancouver Laboratories (VAN) offers the pharmaceutical industry contract development and early clinical phase GMP-compliant manufacturing services and LIPEX® branded processing equipment products. VAN’s mission is to grow both its service and product businesses and to be recognized as the leading CDMO for lipid-based drug development and supplier of processing equipment.
In order to meet the increasing demands of our customers, VAN must operate a highly complex business that is technically competent, responsive, and flexible while working under a quality culture and management system that is commensurate with supplying products and services meeting stringent cGMP requirements.
If you are looking for a career with cutting-edge technology where you can watch new therapies being created, Evonik Vancouver could be the right place for you. With a wide range of opportunities to grow, Evonik Vancouver is a center of excellence and the place to work with LNP or mRNA formulations or vaccines.
Evonik’s Birmingham facility in Alabama provides an integrated range of contract manufacturing services in support of projects from initial feasibility through commercial production of parenteral drug products and excipients, including liquid, lyophilization, and powder-filling aseptic capabilities. We are equipped with multiple cleanrooms, making it possible for us to provide an integrated range of services and technologies, including long-acting injectables such as implants, micro-, and nanoparticles, as well as lipid-based delivery systems such as those used for mRNA vaccines and therapies.
We aspire to be the leader in complex delivery systems and dosage form contract manufacturing— and we are growing! Evonik Birmingham Labs is hiring in parenteral services and products across quality, engineering, manufacturing, facilities, and research to meet expanding health care market demand.
Evonik Industries
Evonik Industries
Evonik Industries
